Tacrolimus-Induced Neurotoxicity After Transplant: A Literature Review.
Verona P, Edwards J, Hubert K, Avorio F, Re VL, Di Stefano R, Carollo A, Johnson H, Provenzani A.
Drug Saf. 2024 May;47(5):419-438. doi: 10.1007/s40264-024-01398-5. Epub 2024 Feb 14.
Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses.
Breijyeh Z, Jubeh B, Bufo SA, Karaman R, Scrano L.
Toxins (Basel). 2021 Feb 5;13(2):117. doi: 10.3390/toxins13020117.
Diagnosing solvent-induced chronic toxic encephalopathy: the effect of underperformance in neuropsychological testing.
Mestdagh I, van Bergen L, Kocken C, Heyvaert V, Cras P, Van Den Eede F.
Int J Psychiatry Clin Pract. 2019 Sep;23(3):171-177. doi: 10.1080/13651501.2019.1571210. Epub 2019 May 13.
Psychological treatment of patients with chronic toxic encephalopathy: lessons from studies of chronic fatigue and whiplash.
van Hout MS, Wekking EM, Berg IJ, Deelman BG.
Psychother Psychosom. 2003 Sep-Oct;72(5):235-44. doi: 10.1159/000071894.
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.
Kalant H.
CMAJ. 2001 Oct 2;165(7):917-28.
Chemotherapy-Related Neurotoxicity.
Taillibert S, Le Rhun E, Chamberlain MC.
Curr Neurol Neurosci Rep. 2016 Sep;16(9):81. doi: 10.1007/s11910-016-0686-x.
Solvent-related chronic toxic encephalopathy as a target in the worker's mental health research.
Ramos A, Jardim SR, Silva-Filho JF.
An Acad Bras Cienc. 2004 Dec;76(4):757-69. doi: 10.1590/s0001-37652004000400010. Epub 2004 Nov 16.
Neurotoxicity of solvents.
Sainio MA Sr.
Handb Clin Neurol. 2015;131:93-110. doi: 10.1016/B978-0-444-62627-1.00007-X.
Myoclonic seizure prior to diagnosis of chronic toxic encephalopathy: a case report.
Van Hooste WL.
J Med Case Rep. 2017 Feb 7;11(1):36. doi: 10.1186/s13256-016-1188-9.
MRI Spectrum of Toxic Encephalopathy-An Institutional Experience.
Biswas S, Pendharkar HS, Murumkar VS.
Neurol India. 2022 Jul-Aug;70(4):1525-1533. doi: 10.4103/0028-3886.355127.
